Novartis to buy UK biotech Myricx Bio in $1.5bn deal - Financial Times

Subscribe to read

* Sign In
* Subscribe

Open side navigation menuOpen search bar

SubscribeSign In

Popular Searches

* What is the latest news on the UK economy?
* Western support for Ukraine
* How will AI be regulated?
* UK inflation vs the world
* How will the UK economy fare in 2026?

* Home
* World
Sections

+ World Home
+ Middle East war
+ Global Economy
+ UK
+ US
+ China
+ Africa
+ Asia Pacific
+ Emerging Markets
+ Europe
+ War in Ukraine
+ Americas
+ Middle East & North Africa
Most Read

+ Andy Burnham needs to start by understanding how little he knows
+ Why OpenAI and Anthropic may struggle to float
+ Baillie Gifford pursues ‘voluntary exits’ under new strategy
+ EasyJet reaches outline agreement on £5.5bn takeover by Castlelake
+ Fifa ‘crossed a red line’ by reversing US star striker’s suspension, Uefa says
* US
Sections

+ US Home
+ US Economy
+ US Companies
+ US Politics & Policy
Most Read

+ Why OpenAI and Anthropic may struggle to float
+ EasyJet reaches outline agreement on £5.5bn takeover by Castlelake
+ Fifa ‘crossed a red line’ by reversing US star striker’s suspension, Uefa says
+ Trump escalates Meloni feud with ‘restraining order needed’ post
+ Big investors commit billions to private credit despite turmoil
* Companies
Sections

+ Companies Home
+ Energy
+ Financials
+ Health
+ Industrials
+ Media
+ Professional Services
+ Retail & Consumer
+ Tech Sector
+ Telecoms
+ Transport
Most Read

+ Why OpenAI and Anthropic may struggle to float
+ Baillie Gifford pursues ‘voluntary exits’ under new strategy
+ EasyJet reaches outline agreement on £5.5bn takeover by Castlelake
+ Big investors commit billions to private credit despite turmoil
+ Son bets the house on AI
* Tech
Sections

+ Tech Home
+ Artificial intelligence
+ Semiconductors
+ Cyber Security
+ Social Media
Most Read

+ Why OpenAI and Anthropic may struggle to float
+ Son bets the house on AI
+ How Bending Spoons built a $23bn tech empire from struggling brands
+ UK regulator warns of ‘arms race’ to keep up with AI use in financial services
+ SaaSpocalypse deferred
* Markets
Sections

+ Markets Home
+ Alphaville
+ Markets Data
+ Private markets
+ Equities
+ Bonds
+ Currencies
+ Commodities
+ Crypto
+ Monetary Policy Radar
+ Wealth Management
+ Moral Money
+ ETF Hub
+ Asset management
Most Read

+ Why OpenAI and Anthropic may struggle to float
+ Baillie Gifford pursues ‘voluntary exits’ under new strategy
+ EasyJet reaches outline agreement on £5.5bn takeover by Castlelake
+ Big investors commit billions to private credit despite turmoil
+ How Bending Spoons built a $23bn tech empire from struggling brands
* Climate
* Opinion
Sections

+ Opinion Home
+ Columnists
+ The FT View
+ The Big Read
+ Lex
+ Obituaries
+ Letters
Most Read

+ Andy Burnham needs to start by understanding how little he knows
+ Why OpenAI and Anthropic may struggle to float
+ The reality check of leaving the abstract world of finance
+ Returning to pre-Trumpian politics won’t save America
+ What’s that smell in the office?
* Lex
* Stock Picking Game
* Life & Arts
Sections

+ Life & Arts Home
+ Arts
+ Books
+ Food & Drink
+ FT Magazine
+ House & Home
+ Style
+ Puzzles
+ Travel
+ FT Globetrotter
Most Read

+ Sky agrees £1.6bn ITV deal as UK broadcasters take on streaming rivals
+ Why wait for The Odyssey? Homer is everywhere in films
+ Everyone loves apprenticeships. So why can’t Britain create more of them?
+ Francis Fukuyama: The problem of equality
+ The Cartier Crash becomes a $2mn watch
* How To Spend It

MenuSearch

* Home
* World
* US
* Companies
* Tech
* Markets
* Climate
* Opinion
* Lex
* Stock Picking Game
* Life & Arts
* How To Spend It

Financial Times

SubscribeSign In

Popular Searches

* What is the latest news on the UK economy?
* Western support for Ukraine
* How will AI be regulated?
* UK inflation vs the world
* How will the UK economy fare in 2026?

Novartis to buy UK biotech Myricx Bio in $1.5bn deal

Subscribe to unlock this article

Try unlimited access

Only

$1

for 4 weeks

Then

$75

per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial.

Keep reading for $1

* Global news & analysis
* Expert opinion
* FT App on Android & iOS
* First FT: the day’s biggest stories
* 20+ curated newsletters
* Follow topics & set alerts with myFT
* FT Videos & Podcasts
* 10 additional monthly gift articles to share
* Lex: FT’s flagship investment column
* 15+ Premium newsletters from leading experts
* FT Digital Edition: our digitised print edition

Explore more offers.

Standard Digital

$45

per month

Essential digital access to quality FT journalism on any device. Pay a year upfront and save 20%.

Select

* Global news & analysis
* Expert opinion
* FT App on Android & iOS
* FT Edit: Access on iOS and web
* FirstFT: the day's biggest stories
* 20+ curated newsletters
* Follow topics & set alerts with myFT
* FT Videos & Podcasts
* 10 monthly gift articles to share

Premium Digital

Complete coverage

$75

per month

Complete digital access to quality FT journalism with expert analysis from industry leaders. Pay a year upfront and save 20%.

Select

* Global news & analysis
* Expert opinion
* FT App on Android & iOS
* FT Edit: Access on iOS and web
* FirstFT: the day's biggest stories
* 20+ curated newsletters
* Follow topics & set alerts with myFT
* FT Videos & Podcasts
* 20 monthly gift articles to share
* Lex: FT's flagship investment column
* 15+ Premium newsletters by leading experts
* FT Digital Edition: our digitised print edition

Premium & FT Weekend Print

$79

per month

FT Weekend newspaper delivered Saturday plus complete digital access.

Select

* FT Weekend Print delivery
* Plus
* Everything in **Premium Digital**

Check whether you already have access via your university

or organisation.

Terms & Conditions apply

Explore our full range of subscriptions.

For individuals

Discover all the plans currently available in your country

DigitalPrintPrint + Digital

For multiple readers

Digital access for organisations. Includes exclusive features and content.

FT Professional

Why the FT?

See why over a million readers pay to read the Financial Times.

Find out why

Useful links

Support

Help CentreContact UsAbout UsAccessibilityCareersSuppliers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency Converter

Community & Events

FT Live EventsFT ForumsFT Leaders Academy

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2026. FT (Financial Times) and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.

Edition:

International

UK

Subscribe for full access

Top sections

* Home
* World
+ Middle East war
+ Global Economy
+ UK
+ US
+ China
+ Africa
+ Asia Pacific
+ Emerging Markets
+ Europe
+ War in Ukraine
+ Americas
+ Middle East & North Africa
* US
+ US Economy
+ US Companies
+ US Politics & Policy
* Companies
+ Energy
+ Financials
+ Health
+ Industrials
+ Media
+ Professional Services
+ Retail & Consumer
+ Tech Sec